Dr. Joga Srujana Specialist in Medical Oncology

Area of Expertise

● Dr. Srujana Joga is an experienced medical oncologist who can be consulted at HCG Cancer Centre, a leading hospital for cancer treatment in Ongole.

● She is well-versed in administering different types of medical oncology treatments or systemic treatments, such as chemotherapy, targeted therapy, immunotherapy, and hormone therapy, for a broad spectrum of cancers.

● She also has a special interest in the HIPEC procedure for abdominal malignancies.

Research & Publications

Research

● Thesis - A study of Molecular subtypes of Colorectal cancer and their clinico-pathological correlation in a tertiary care cancer hospital in India (Feb 2019 –March 2020).

● Co-investigator in DESTINY BREAST -011, ASTEFANIA trial, Destiny BREAST -06 and 07 trials.

● Co-investigator in ICMR project “Hospital-based cancer registries in India” (April 2022 – March 2027).

Publications

● A Study of Molecular Subtypes (Profile) of Colorectal Cancer and Their Correlation with Clinical and Pathological Profile in a Tertiary Care Center in India. South Asian Journal of Cancer. 2025 Jan 31.

● Real World Experience with Osteosarcoma from a Tertiary Cancer Centre in India. Journal of Cancer Science and Clinical Therapeutics. 7 (2023): 93-99.

● P-21 Molecular subtypes (profile) of colorectal cancer and their correlation with clinical and pathological profile in a tertiary care centre in India. Annals of Oncology, Volume 33, S253 - S254.

● The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not?. Cancer Research, Statistics, and Treatment. 2021 Jul 1;4(3):579-80.

● Angiogenesis in Cancer. Indian J Med Paediatr Oncol 2021; 42(02): 168-171.

● Nanotechnology in oncology. Indian J Med Paediatr Oncol 2021; 42(01): 093-095.

● Artificial Intelligence: A New Tool in Oncologist's Armamentarium. Indian J Med Paediatr Oncol 2021; 42(06): 511-517.

● Spontaneous pulmonary arterial embolization: A rare complication of the silicon-based peripherally inserted central venous catheter (PICC). J Vasc Access. 2022 May;23(3):471-473.

● Immune checkpoint inhibitors in advanced non-small cell lung cancer: A metacentric experience from India. Curr Probl Cancer. 2020 Jun;44(3):100549.

● Liquid biopsy in non-small-cell lung cancer: Ready for prime time? Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):142.

● Real-World Epidemiological data of PD-L1 expression in metastatic non-small lung cancer (NSCLC) wild type: A single tertiary centre in India experience. South Asian Journal of Cancer. Accepted on 24/02/2020.

Other Doctors